Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Diazepam

A benzodiazepine that enhances the action of the neurotransmitter GABA, synthesised in 1959 by chemist Leo Sternbach and on the market since 1963: it is used for anxiety, muscle spasms and seizures. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Sternbach reached the benzodiazepines almost by chance: in 1957, while tidying the laboratory, he had a long-shelved compound tested, chlordiazepoxide, which became the founder of the family.

DiazepamGo to the active ingredient →
DiazepamActive ingredientDiazepamCat. No. P-D087-001CAS 439-14-5
Diazepam-d5Isotopically labelledDiazepam-d5Cat. No. P-D087-007CAS 65854-76-4

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceDiazepam CRSEDQM code D0940000Family Diazepam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.